Early and Sharp Rise in Flu Cases Alarms Health Officials
The UK is experiencing an unusually early and sharp increase in flu cases this winter, driven by a new and concerning strain known as H3N2. Doctors are warning that this could signal a severe flu season ahead, with case numbers already three times higher than at the same point in 2024.
Vaccination Uptake Lags Behind as Virus Spreads
Health bosses report that a significant 84% of confirmed flu cases where sub-typing was available have been identified as the H3N2 subtype. Despite the early arrival of the virus, vaccination rates remain worryingly low in some areas. In the Black Country, over 65% of eligible residents have not yet received their flu jab, with similar figures of around 70% in Birmingham and Solihull.
Sally Roberts, chief nursing officer for the NHS Black Country Integrated Care Board, issued a strong plea: “We know that these viruses can cause serious illness, especially in people who are more vulnerable. Whether you’re a member of the public, a patient, or a healthcare worker, I’d strongly encourage everyone who is eligible to come forward for their flu vaccination.”
Urgent Calls for Protection to Ease NHS Pressure
There are growing fears that the early surge, combined with a potential rise in Covid-19 cases, could leave hospitals overwhelmed during the coldest months. Public health directors are emphasising the urgency of vaccination.
Dr Nadia Inglis, Director of Public Health at Walsall Council, stated: “With flu arriving earlier and hitting harder this year, it’s more important than ever that eligible residents come forward for their vaccination. The flu vaccine is safe, effective and can prevent serious illness especially for our most vulnerable.”
Paul Fisher, a UKHSA West Midlands consultant, provided a sobering reminder: “Every year, thousands of people are admitted to hospital after catching flu, and tragically, many also die. Many of these deaths could be prevented by eligible people having their flu vaccination.” He added that early data suggests this season's vaccine is providing important protection against the new virus subclade.
